|
1) Kameda H, Miyoshi H, Shimizu C, Nagai S, Nakamura A, Kondo T, Chida D, and Atsumi T. Expression and regulation of neuromedin B in pituitary corticotrophs of male melanocortin 2 receptor-deficient mice. Endocrinology. Volume 155, Issue 7, pages 2492-2499, July 2014.
2) Kameda H, Nakagaki O, Nagai S, Kondo T, Atsumi T, Chida D, Iwakura Y, and Shimizu C. Analysis of pituitary gene expression of melanocortin 2 receptor deficient mice. ACTH related peptides. Volume 24, pages 12-14, 2013.
3) Kameda H, Nagai S, Miyoshi H, Kondo T, Sawada T, Nakagaki A, Kimachi K, Cho KY, Hirai A, Tajima K, Nomoto H, Miyoshi A, Shimizu C, Yoshioka N, and Koike T. Influence of Pegvisomant Administration on Glucose Tolerance in Three Cases of Acromegaly. Journal of the Japan Diabetes Society. Volume 54, Issue 8, pages 686-690, September 2011.
4) Araki T, Liu X, Kameda H, Tone Y, Fukuoka H, Tone M, Melmed S： EGFR Induces E2F1-Mediated Corticotroph Tumorigenesis. Journal of the Endocrine Society, Volume 1, Issue 2, 1 February 2017, Pages 127–143.
5) Nomoto H, Kimachi K, Miyoshi H, Kameda H, Cho KY, Nakamura A, Nagai S, Kondo T, Atsumi T： Effects of 50 mg vildagliptin twice daily vs. 50 mg sitagliptin once daily on blood glucose fluctuations evaluated by long-term self-monitoring of blood glucose. Endocrione Journal. 2017 Apr 29;64(4):417-424.
6) Takahashi K, Nakamura A, Miyoshi H, Nomoto H, Kameda H, Cho KY, Nagai S, Shimizu C, Taguri M, Terauchi Y, Atsumi T： Factors associated with an inadequate hypoglycemia in the insulin tolerance test in Japanese patients with suspected or proven hypopituitarism. Endocrine Journal. 2017 Apr 29;64(4):387-392.
7) Ohtaka K, Fujisawa Y, Takada F, Hasegawa Y, Miyoshi T, Hasegawa T, Miyoshi H, Kameda H, Kurokawa-Seo M, Fukami M, Ogata T: FGFR1 Analyses in Four Patients with Hypogonadotropic Hypogonadism with Split-Hand/Foot Malformation: Implications for the Promoter Region. Human Mutatation. 2017 May;38(5):503-506.
8) Nakamura A, Mitsuhashi T, Takano Y, Miyoshi H, Kameda H, Nomoto H, Nagai S, Hatanaka Y, Shimizu C, Terauchi Y, Atsumi T: Usefulness of the octreotide test in Japanese patients for predicting the presence/absence of somatostatin receptor 2 expression in insulinomas. Endocrine Journal. 2016;63(2):135-42.
9) Yamamoto C, Miyoshi H, Fujiwara Y, Kameda R, Ichiyama M, Nomoto H, Kameda H, Nakamura A, Atsumi T: Degludec is superior to glargine in terms of daily glycemic variability in people with type 1 diabetes mellitus. Endocrine Journal. 2016;63(1):53-60.
10) Ono Y, Kameda H, and Cho KY. Mitiglinide/voglibose fixed-dose combination improves postprandial glycemic excursions in Japanese patients with type 2 diabetes mellitus. Expert Opinion on Pharmacotherapy. Volume 14, No. 4, Pages 361-370, March 2013.
11) Miyoshi A, Nagai S, Takeda M, Kondo T, Nomoto H, Kameda H, Hirai A, Cho KY, Kimachi K, Shimizu C, Atsumi T, and Miyoshi H. Ovarian morphology and prevalence of polycystic ovary syndrome in Japanese women with type 1 diabetes mellitus. Journal of Diabetes Investigation. Volume 4, Issue 3, pages 326–329, May 2013.
|
